4013.SR
Dr. Sulaiman Al Habib Medical Services Group Company
SaudiSAREQUITY
DELAYED
Last price
237.20
▼ 1.20 (0.50%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
238.10
Prev close
238.40
Day high
238.20
Day low
235.50
Volume
59.15K
Market cap
—
P/E (TTM)
—
52W range
210.10 – 281.20
Trailing performance
Returnvs SPY
1W
+4.12%
+5.5%
1M
+12.01%
+8.3%
3M
+9.18%
+6.1%
6M
-5.63%
-16.7%
YTD
-7.47%
-19.8%
1Y
-4.04%
-24.0%
3Y
-9.65%
-83.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on 4013.SR open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $13.71B | $11.20B | $9.51B | $8.31B | +22.4% |
| Operating revenue | $13.71B | $11.20B | $9.51B | $8.31B | +22.4% |
| Cost of revenue | $9.50B | $7.46B | $6.24B | $5.56B | +27.4% |
| Gross profit | $4.21B | $3.74B | $3.27B | $2.75B | +12.4% |
| Selling, general & admin | $342.32M | $235.15M | $214.01M | $182.18M | +45.6% |
| Total operating expense | $1.57B | $1.37B | $1.16B | $1.04B | +14.3% |
| Operating income | $2.64B | $2.37B | $2.11B | $1.71B | +11.2% |
| Net interest income | -$306.38M | -$122.78M | -$1.77M | -$20.18M | -149.5% |
| Pre-tax income | $2.52B | $2.41B | $2.17B | $1.80B | +4.4% |
| Tax provision | $27.61M | $42.90M | $68.52M | $107.71M | -35.6% |
| Net income | $2.40B | $2.32B | $2.05B | $1.65B | +3.7% |
| Net income to common | $2.40B | $2.32B | $2.05B | $1.65B | +3.7% |
| Basic EPS | 6.86 | 6.62 | 5.85 | 4.72 | +3.6% |
| Diluted EPS | 6.86 | 6.62 | 5.85 | 4.72 | +3.6% |
| EBIT | $2.86B | $2.58B | $2.24B | $1.85B | +11.0% |
| EBITDA | $3.53B | $3.00B | $2.55B | $2.16B | +17.8% |
| Basic shares | 350.00M | 350.00M | 350.00M | 350.00M | 0.0% |
| Diluted shares | 350.00M | 350.00M | 350.00M | 350.00M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $2.28B | $2.89B | $2.62B | $2.75B | -21.1% |
| Cash & short-term investments | $2.28B | $2.89B | $2.62B | $2.75B | -21.1% |
| Accounts receivable | $1.62B | $1.11B | $703.12M | $741.71M | +46.1% |
| Inventory | $1.03B | $846.88M | $543.06M | $490.39M | +21.4% |
| Total current assets | $5.43B | $5.32B | $4.14B | $4.16B | +2.0% |
| Property, plant & equipment | $17.30B | $14.77B | $11.16B | $7.94B | +17.1% |
| Total assets | $23.20B | $20.56B | $15.80B | $12.58B | +12.9% |
| Total current liabilities | $4.72B | $4.16B | $3.30B | $2.59B | +13.4% |
| Current debt | $96.04M | $96.04M | $96.04M | $167.65M | 0.0% |
| Long-term debt | $8.73B | $7.66B | $4.81B | $3.03B | +14.0% |
| Total debt | $9.30B | $8.17B | $5.18B | $3.52B | +14.0% |
| Total liabilities | $14.78B | $12.95B | $9.03B | $6.48B | +14.1% |
| Retained earnings | $4.40B | $3.68B | $1.94B | $1.50B | +19.8% |
| Shareholder equity | $7.90B | $7.18B | $6.49B | $5.88B | +10.1% |
| Working capital | $708.62M | $1.16B | $838.68M | $1.57B | -38.8% |
| Net tangible assets | $7.90B | $7.18B | $6.49B | $5.88B | +10.1% |
| Shares issued | 350.00M | 350.00M | 350.00M | 350.00M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $2.52B | $2.41B | $2.17B | $1.80B | +4.4% |
| Depreciation & amortisation | $671.62M | $420.80M | $312.68M | $309.22M | +59.6% |
| Change in working capital | -$318.38M | -$347.09M | $424.62M | $514.36M | +8.3% |
| Operating cash flow | $3.40B | $2.97B | $3.24B | $2.84B | +14.5% |
| Capital expenditure | -$2.98B | -$3.83B | -$3.50B | -$1.51B | +22.1% |
| Investing cash flow | -$2.97B | -$3.78B | -$3.49B | -$1.94B | +21.3% |
| Dividends paid | -$1.66B | -$1.64B | -$1.44B | -$1.14B | -1.3% |
| Financing cash flow | -$1.04B | $1.08B | $115.87M | -$801.12M | -196.8% |
| Free cash flow | $418.64M | -$858.19M | -$252.74M | $1.33B | +148.8% |
| End cash position | $2.28B | $2.89B | $2.62B | $2.75B | -21.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $4.01B | $3.44B | $3.70B | $3.38B | $3.16B | +16.6% |
| Operating revenue | $4.01B | $3.44B | $3.70B | $3.38B | $3.16B | +16.6% |
| Cost of revenue | $2.78B | $2.48B | $2.64B | $2.32B | $2.13B | +12.3% |
| Gross profit | $1.22B | $955.97M | $1.06B | $1.07B | $1.03B | +27.8% |
| Selling, general & admin | $451.60M | $368.22M | -$865.40M | $421.12M | $402.38M | +22.6% |
| Total operating expense | $451.60M | $368.22M | $360.02M | $421.12M | $402.38M | +22.6% |
| Operating income | $770.41M | $587.75M | $702.77M | $644.87M | $625.93M | +31.1% |
| Net interest income | -$104.49M | -$104.11M | -$58.40M | -$83.38M | -$78.65M | -0.4% |
| Pre-tax income | $725.95M | $539.55M | $679.03M | $615.53M | $589.71M | +34.5% |
| Tax provision | $20.63M | $26.15M | -$5.13M | $13.18M | $9.93M | -21.1% |
| Net income | $662.66M | $503.29M | $651.16M | $591.02M | $557.01M | +31.7% |
| Net income to common | $662.66M | $503.29M | $651.16M | $591.02M | $557.01M | +31.7% |
| Basic EPS | 1.89 | 1.44 | — | 1.69 | 1.59 | +31.3% |
| Diluted EPS | 1.89 | 1.44 | — | 1.69 | 1.59 | +31.3% |
| EBIT | $830.45M | $643.66M | $769.84M | $698.92M | $668.36M | +29.0% |
| EBITDA | $1.05B | $856.58M | $955.02M | $862.25M | $819.91M | +22.8% |
| Basic shares | 350.00M | 350.00M | — | 350.00M | 350.00M | 0.0% |
| Diluted shares | 350.00M | 350.00M | — | 350.00M | 350.00M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.32B | $2.42B | $2.28B | $2.18B | $2.55B | -3.9% |
| Cash & short-term investments | $2.32B | $2.42B | $2.28B | $2.18B | $2.55B | -3.9% |
| Accounts receivable | $1.94B | $1.63B | $1.62B | $1.83B | $1.18B | +18.9% |
| Inventory | $1.23B | $1.15B | $1.03B | $1.12B | $929.03M | +7.0% |
| Total current assets | $6.20B | $5.65B | $5.43B | $5.73B | $5.24B | +9.8% |
| Property, plant & equipment | $17.93B | $17.57B | $17.30B | $16.28B | $15.65B | +2.0% |
| Total assets | $24.69B | $23.77B | $23.20B | $22.48B | $21.36B | +3.9% |
| Total current liabilities | $5.53B | $4.96B | $4.72B | $4.87B | $4.43B | +11.6% |
| Current debt | $280.24M | $70.57M | $96.04M | $157.87M | $157.87M | +297.1% |
| Long-term debt | $8.94B | $8.98B | $8.73B | $8.43B | $8.00B | -0.4% |
| Total debt | $9.67B | $9.50B | $9.30B | $9.03B | $8.59B | +1.8% |
| Total liabilities | $15.85B | $15.28B | $14.78B | $14.52B | $13.61B | +3.7% |
| Retained earnings | $4.76B | $4.45B | $4.40B | $3.99B | $3.79B | +7.0% |
| Shareholder equity | $8.26B | $7.95B | $7.90B | $7.49B | $7.29B | +3.9% |
| Working capital | $667.74M | $692.10M | $708.62M | $859.40M | $813.32M | -3.5% |
| Net tangible assets | $8.26B | $7.95B | $7.90B | $7.49B | $7.29B | +3.9% |
| Shares issued | 350.00M | 350.00M | 350.00M | 350.00M | 350.00M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $725.95M | $539.55M | $679.03M | $615.53M | $589.71M | +34.5% |
| Depreciation & amortisation | $221.29M | $212.92M | $185.17M | $163.34M | $151.55M | +3.9% |
| Change in working capital | -$325.53M | $218.05M | $44.33M | -$488.92M | -$99.56M | -249.3% |
| Operating cash flow | $777.67M | $1.05B | $1.04B | $462.77M | $733.59M | -26.3% |
| Capital expenditure | -$563.15M | -$472.63M | -$512.79M | -$749.62M | -$934.32M | -19.2% |
| Investing cash flow | -$563.15M | -$539.84M | -$512.79M | -$749.62M | -$934.32M | -4.3% |
| Dividends paid | -$353.50M | -$458.50M | -$423.50M | -$392.00M | -$430.50M | +22.9% |
| Financing cash flow | -$307.67M | -$381.25M | -$353.75M | -$76.61M | -$141.76M | +19.3% |
| Free cash flow | $214.51M | $582.20M | $524.11M | -$286.85M | -$200.73M | -63.2% |
| End cash position | $2.32B | $2.42B | $2.28B | $2.18B | $2.55B | -3.9% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
233.00
+1.80% from price
SMA 20
233.90
+1.67% from price
SMA 50
222.66
+6.80% from price
SMA 100
226.80
+4.59% from price
SMA 200
239.80
-0.84% from price
EMA 12
233.64
+1.52% from price
EMA 26
230.03
+3.12% from price
EMA 50
227.08
+4.46% from price
RSI (14)
64.4
Neutral
MACD (12,26,9)
3.61
Hist -0.11
ATR (14)
3.94
1.66% of price
Realised vol 30D
21.3%
Annualised
Bollinger upper
242.22
20, 2σ
Bollinger lower
225.58
20, 2σ
50 / 200 cross
Death
222.66 vs 239.80
Trend bias
Below 200
-0.84%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.08
Less volatile than market
Correlation to SPY
-0.05
Largely independent
Realised vol 30D
21.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-24.6%
Peak to trough
Max drawdown 5Y
-37.3%
Peak to trough
ATR 14
3.94
1.66% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Solana Is Beating Ethereum in Tokenized Assets. That Might Not Make It the Better Buy.
Motley Fool · 16m ago
Zcash Hits Eight-Year High After Grayscale Advances U.S. ETF Push
CryptoProwl · 16m ago
Another travel company shuts down and cancels all trips, refunds available
TheStreet · 17m ago
How Your Social Security Benefit Is Actually Calculated
Motley Fool · 17m ago
Pegula dethrones Swiatek to reach Cincinnati final
AFP · 18m ago
Canada to impose retaliatory tariffs on US steel, electronics, other products, Carney says
Reuters · 20m ago
Quantum Computing vs. Red Cat: Which High-Growth Innovation Stock Is a Better Buy in 2026?
Motley Fool · 21m ago
IPO Fever Heats Up for OpenAI and Anthropic
Motley Fool · 24m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.